DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 2813-2820

  Couper, Kevin N ^a   Nielsen, Henrik V ^b   Petersen, Eskild ^b   Roberts, Fiona ^c   Roberts, Craig W ^a   Alexander, James ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b STATENS SERUM INSTITUT   (Denmark)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

Congenital disease; DNA vaccine; Toxoplasma gondii

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; MEMBRANE ANTIGEN;

ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; IMMUNE RESPONSE; MOUSE STRAIN; NONHUMAN; PLASMID; PREGNANCY; PRIORITY JOURNAL; SURFACE PROPERTY; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION; VIRULENCE;

EID: 0038513466     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00163-4     Document Type: Article

References (30)

1. Cook G.C. Toxoplasma gondii infection: a potential danger to the unborn fetus and AIDS sufferer. Q. J. Med. 74:1990;3-19.
2. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:1992;211-222.
3. + T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immunol. 84:1991;207-212.
4. + T-cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147:1991;3501-3506.
5. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science. 240:1988;516.
6. + T cells determine cyst numbers in Toxoplasma gondii infection. J. Immunol. 145:1990;3438.
7. Buxton D., Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology. 110:1995;11-16.
8. Letscher-Bru V., Villard O., Risse B., Zauke M., Klein J.-P., Kien T.T. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infect. Immun. 66:1998;4503-4506.
9. Bülow R., Boothroyd J.C. Protection of mice from fatal Toxoplasma gondii infection by immunization with P30 antigen in liposomes. J. Immunol. 147:1991;3496-3500.
10. Kasper L.H., Currie K.M., Bradley M.S. An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii. J. Immunol. 134:1985;3426-3431.
11. Grun J.L., Maurer R.T. Different T-helper cell subsets elicited in mice utilising two different adjuvant vehicles: the role of endogenous IL-1 in proliferative responses. Cell. Immunol. 121:1989;134-135.
12. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G.et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9519-9523.
13. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG-1 gene. Infect. Immun. 67:1999;6358-6363.
14. Angus C.W., Klivington-Evans D., Dubey J.P., Kovacs J.A. Immunization with a DNA plasmid encoding the SAG-1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J. Infect. Dis. 181:2000;317-324.
15. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D.et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect. Immun. 68:2000;38-45.
16. Desolme B., Mévélec M.-N., Buzoni-Gatel D., Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine. 18:2000;2512-2521.
17. Roberts C.W., Alexander J. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology. 104:1992;19-23.
18. Eichenwald H. Experimental toxoplasmosis. Transmission of the infection in utero and through the milk of lactating female mice. Am. J. Dis. Child. 76:1948;307-315.
19. Denkers E.Y., Gazzanelli R. Regulation and function of T-cell mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:1998;569-588.
20. Alexander J., Hunter C.A. Immunoregulation during toxoplasmosis. Immunology of intracellular parasitism. Chem. Immunol. 70:1998;81-102.
21. Leyva R., Hérion P., Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol. Res. 87:2001;70-79.
22. Geissler M., Gesien A., Tokushige K., Wands J.R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1997;1231-1237.
23. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today. 19:1998;89-97.
24. Haumont M., Delhaye L., Garcia L., Jurado M., Mazzu P., Daminet V.et al. Protective immunity against congenital toxoplasmosis with recombinant SAG-1 protein in a guinea pig model. Infect. Immun. 68:2000;4948-4953.
25. Sibley L.D., Howe D.K. Genetic basis of pathogenicity in toxoplasmosis. Curr. Top. Microbiol. Immunol. 219:1996;3-16.
26. Roberts C.W., Walker W., Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin. Microbiol. Rev. 14:2001;476-488.
27. Roberts C.W., Brewer J.M., Alexander J. Congenital toxoplasmosis in the BALB/c mouse: prevention of vertical disease transmission and fetal death by vaccination. Vaccine. 12:1994;1389-1394.
28. Mishima M., Xuan X., Shioda A., Omata Y., Fujisaki K., Nagasawa H.et al. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1. J. Vet. Med. Sci. 63:2001;433-438.
29. Parmley S., Slifer T., Araujo F. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts. J. Infect. Dis. 185:2002;90-95.
30. Alexander J., Jebbari H., Bluethmann H., Satoskar A., Roberts C.W. Immunological control of Toxoplasma gondii and appropriate vaccine design. Curr. Top. Microbiol. Immunol. 219:1996;183-195.